secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001654954-23-014446
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata Therapeutics receives Nasdaq delisting notice for bid price non-compliance
--------------------------------------------------------------------------------

- Nasdaq notice dated Nov 15, 2023 for failing $1.00 minimum bid price for 30 consecutive business days.
- Company has 180 calendar days, until May 13, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, may qualify for additional 180-day period with reverse stock split and other conditions.
- Company is evaluating options to regain compliance; business operations unaffected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423014446/0001654954-23-014446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423014446/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-014446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer